Novozymes Statistics
Total Valuation
Novozymes has a market cap or net worth of 32.54 billion. The enterprise value is 34.23 billion.
| Market Cap | 32.54B |
| Enterprise Value | 34.23B |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -8.56% |
| Shares Change (QoQ) | +68.44% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 343.64M |
Valuation Ratios
The trailing PE ratio is 65.65 and the forward PE ratio is 29.40.
| PE Ratio | 65.65 |
| Forward PE | 29.40 |
| PS Ratio | 7.42 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 22.24 |
| P/FCF Ratio | 49.22 |
| P/OCF Ratio | 31.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.89, with an EV/FCF ratio of 51.78.
| EV / Earnings | 69.07 |
| EV / Sales | 7.22 |
| EV / EBITDA | 24.89 |
| EV / EBIT | 31.94 |
| EV / FCF | 51.78 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.66 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | 2.78 |
| Interest Coverage | 11.41 |
Financial Efficiency
Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 7.25%.
| Return on Equity (ROE) | 6.97% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.25% |
| Return on Capital Employed (ROCE) | 6.64% |
| Revenue Per Employee | 414,444 |
| Profits Per Employee | 46,831 |
| Employee Count | 10,582 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Novozymes has paid 168.94 million in taxes.
| Income Tax | 168.94M |
| Effective Tax Rate | 25.42% |
Stock Price Statistics
The stock price has increased by +12.57% in the last 52 weeks. The beta is 0.54, so Novozymes's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +12.57% |
| 50-Day Moving Average | 70.74 |
| 200-Day Moving Average | 62.78 |
| Relative Strength Index (RSI) | 43.92 |
| Average Volume (20 Days) | 54,217 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novozymes had revenue of 4.39 billion and earned 495.57 million in profits. Earnings per share was 1.71.
| Revenue | 4.39B |
| Gross Profit | 2.31B |
| Operating Income | 996.22M |
| Pretax Income | 664.50M |
| Net Income | 495.57M |
| EBITDA | 1.28B |
| EBIT | 996.22M |
| Earnings Per Share (EPS) | 1.71 |
Balance Sheet
The company has 269.67 million in cash and 1.84 billion in debt, giving a net cash position of -1.57 billion.
| Cash & Cash Equivalents | 269.67M |
| Total Debt | 1.84B |
| Net Cash | -1.57B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.14B |
| Book Value Per Share | 26.04 |
| Working Capital | 838.41M |
Cash Flow
In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -365.54 million, giving a free cash flow of 661.05 million.
| Operating Cash Flow | 1.03B |
| Capital Expenditures | -365.54M |
| Free Cash Flow | 661.05M |
| FCF Per Share | n/a |
Margins
Gross margin is 52.73%, with operating and profit margins of 22.72% and 11.30%.
| Gross Margin | 52.73% |
| Operating Margin | 22.72% |
| Pretax Margin | 15.15% |
| Profit Margin | 11.30% |
| EBITDA Margin | 29.12% |
| EBIT Margin | 22.72% |
| FCF Margin | 15.07% |
Dividends & Yields
This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.77%.
| Dividend Per Share | 0.54 |
| Dividend Yield | 0.77% |
| Dividend Growth (YoY) | -4.48% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.46% |
| Buyback Yield | 8.56% |
| Shareholder Yield | 9.33% |
| Earnings Yield | 1.52% |
| FCF Yield | 2.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 9, 2011. It was a forward split with a ratio of 5.
| Last Split Date | Dec 9, 2011 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Novozymes has an Altman Z-Score of 5.71 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.71 |
| Piotroski F-Score | 3 |